L3HYPDH
Trans-3-hydroxy-L-proline dehydratase
Also known as: C14orf149, FLJ25436, T3HPD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96EM0
- Gene
- L3HYPDH
- Ensembl
- ENSG00000126790
- Chromosome
- 14
- Canonical length
- 354 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a dehydratase that converts trans-3-hydroxy-L-proline to delta(1)-pyrroline-2-carboxylate. This enzyme may function to degrade dietary proteins that contain trans-3-hydroxy-L-proline as well as other proteins such as collagen IV. The encoded protein can be converted to an epimerase by changing a threonine to a cysteine at a catalytic site. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
354 residues, UniProt reviewed canonical sequence.
>Q96EM0|L3HYPDH
1 MESALAVPRL PPHDPGTPVL SVVDMHTGGE PLRIVLAGCP EVSGPTLLAK RRYMRQHLDH
61 VRRRLMFEPR GHRDMYGAVL VPSELPDAHL GVLFLHNEGY SSMCGHAVLA LGRFALDFGL
121 VPAPPAGTRE ARVNIHCPCG LVTAFVACED GRSHGPVRFH SVPAFVLATD LMVDVPGHGK
181 VMVDIAYGGA FYAFVTAEKL GLDICSAKTR DLVDAASAVT EAVKAQFKIN HPDSEDLAFL
241 YGTILTDGKD AYTKEPTTNI CVFADEQVDR SPTGSGVTAR IALQYHKGLL ELNQMRAFKS
301 SATGSVFTGK AVREAKCGDF KAVIVEVSGQ AHYTGTASFI IEDDDPLRDG FLLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against L3HYPDH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 23 nTPM
- adipose tissue: 17 nTPM
- ovary: 17 nTPM
- fallopian tube: 17 nTPM
- lymph node: 16 nTPM
- kidney: 16 nTPM
Single-cell type
- adipocytes: 54 nCPM
- cardiomyocytes: 41 nCPM
- epicardial cells: 41 nCPM
- megakaryocyte progenitors: 37 nCPM
- proximal tubule cells: 37 nCPM
- ependymal cells: 32 nCPM
Immune cell
- myeloid DC: 5.7 nTPM
- NK-cell: 5.6 nTPM
- intermediate monocyte: 5.1 nTPM
- classical monocyte: 3.5 nTPM
- gdT-cell: 3.3 nTPM
- plasmacytoid DC: 3.2 nTPM
Brain region
- choroid plexus: 26 nTPM
- cerebellum: 25 nTPM
- medulla oblongata: 22 nTPM
- white matter: 21 nTPM
- midbrain: 17 nTPM
- hypothalamus: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.36
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
- hydro-lyase activity
- trans-L-3-hydroxyproline dehydratase activity
Protein domainsUniProt · Pfam · InterPro
- Proline racemase family
- Proline racemase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads L3HYPDH as an antibody target. Whether an autoantibody or antibody against L3HYPDH could matter depends on whether native L3HYPDH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
L3HYPDH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label L3HYPDH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...